Exact Sciences Corp.

NASDAQ:EXAS

50.46

-1.75 (-3.35%)

6:30:31 PM EDT: $50.80 +0.34 (+0.67%)

Market Cap (Intraday)	9.52B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	136.38

See more stats

Estimates Current Quarter

Revenue	$773.46 Million
Adjusted EPS	-$0.13

See more estimates

10-Day MA	$52.71
50-Day MA	$54.26
200-Day MA	$54.66

See more pivots

Exact Sciences Corp. Stock, NASDAQ:EXAS

5505 Endeavor Lane, Madison, Wisconsin 53719

United States of America

Phone: +1.608.284.5700

Number of Employees: 7000

http://www.exactsciences.com

Description

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.